5 Stocks to Buy with Exponential Growth

Page 5 of 5

1. CRISPR Therapeutics AG (NASDAQ:CRSP)

Average Sales Growth Over the Past 5 Years: 27206%

CRISPR Therapeutics AG (NASDAQ:CRSP) is perhaps one of the most popular gene editing platform companies. Last month, Mizuho started covering CRISPR Therapeutics AG (NASDAQ:CRSP) with a Buy rating. CRISPR Therapeutics AG (NASDAQ:CRSP) likes the company’s editing platform and its potential to become the next Genentech. Mizuho set an $82 price target on CRISPR Therapeutics AG (NASDAQ:CRSP).

As of the end of the second quarter of 2023, 30 hedge funds tracked by Insider Monkey had stakes in CRISPR Therapeutics AG (NASDAQ:CRSP). The biggest stakeholder of CRISPR Therapeutics AG (NASDAQ:CRSP) during this period was Catherine D. Wood’s ARK Investment Management which owns a $412 million stake in CRISPR Therapeutics AG (NASDAQ:CRSP).

You can also take a peek at 15 Most Innovative Companies in Canada and 15 Best Casino Stocks To Buy Heading Into 2024.

Page 5 of 5